
Marie Thibault
Stock Analyst at BTIG
(0.06)
# 4,680
Out of 4,704 analysts
745
Total ratings
39.6%
Success rate
-9.2%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KMTS Kestra Medical Technologies | Reiterated: Buy | $32 | $25.54 | +25.29% | 11 | Sep 2, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $25 → $28 | $23.29 | +20.25% | 5 | Sep 1, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $45 → $55 | $51.52 | +6.75% | 54 | Aug 24, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $134 | $108.33 | +23.70% | 54 | Aug 20, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2 | $0.8133 | +145.91% | 6 | Aug 20, 2026 | |
| CBLL CeriBell | Reiterated: Buy | $28 → $30 | $24.72 | +21.36% | 13 | Aug 18, 2026 | |
| SENS Senseonics Holdings | Maintained: Hold | n/a | $9.63 | - | 40 | Aug 7, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $185 | $123.07 | +50.32% | 62 | Aug 7, 2026 | |
| PODD Insulet | Downgraded: Hold | n/a | $147.48 | - | 51 | Aug 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $80 → $90 | $87.90 | +2.39% | 56 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $89.90 | +22.36% | 44 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $17 | $16.48 | +3.16% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $47.80 | +35.98% | 78 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.53 | - | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2668 | - | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $102.92 | -18.38% | 13 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.80 | - | 28 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.08 | - | 8 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $3.59 | +317.83% | 18 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $74.29 | n/a | 55 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $319.97 | n/a | 1 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $322.17 | n/a | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 37 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 | $94.17 | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.88 | n/a | 23 | Dec 16, 2022 |
Kestra Medical Technologies
Sep 2, 2026
Reiterated: Buy
Price Target: $32
Current: $25.54
Upside: +25.29%
MiniMed Group
Sep 1, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $23.29
Upside: +20.25%
AtriCure
Aug 24, 2026
Reiterated: Buy
Price Target: $45 → $55
Current: $51.52
Upside: +6.75%
Abbott Laboratories
Aug 20, 2026
Maintained: Buy
Price Target: $134
Current: $108.33
Upside: +23.70%
Hyperfine
Aug 20, 2026
Reiterated: Buy
Price Target: $2
Current: $0.8133
Upside: +145.91%
CeriBell
Aug 18, 2026
Reiterated: Buy
Price Target: $28 → $30
Current: $24.72
Upside: +21.36%
Senseonics Holdings
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $9.63
Upside: -
iRhythm Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $185
Current: $123.07
Upside: +50.32%
Insulet
Aug 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $147.48
Upside: -
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $87.90
Upside: +2.39%
Jul 24, 2026
Reiterated: Buy
Price Target: $110
Current: $89.90
Upside: +22.36%
Jul 13, 2026
Maintained: Buy
Price Target: $16 → $17
Current: $16.48
Upside: +3.16%
Jul 10, 2026
Maintained: Buy
Price Target: $65
Current: $47.80
Upside: +35.98%
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $3.53
Upside: -
Jul 7, 2026
Rated: Hold
Price Target: n/a
Current: $0.2668
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $84
Current: $102.92
Upside: -18.38%
Jun 15, 2026
Maintained: Hold
Price Target: n/a
Current: $5.80
Upside: -
Feb 18, 2026
Maintained: Hold
Price Target: n/a
Current: $5.08
Upside: -
Feb 18, 2026
Maintained: Buy
Price Target: $15
Current: $3.59
Upside: +317.83%
Apr 10, 2025
Reiterated: Buy
Price Target: $62
Current: $74.29
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $150
Current: $319.97
Upside: n/a
Jul 26, 2023
Rated: Buy
Price Target: n/a
Current: $322.17
Upside: n/a
Jul 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Feb 21, 2023
Rated: Hold
Price Target: $89
Current: $94.17
Upside: n/a
Dec 16, 2022
Rated: Hold
Price Target: n/a
Current: $2.88
Upside: n/a